FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 41 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $614,078 | -12.9% | 81,768 | +2.4% | 0.00% | – |
| Q2 2023 | $705,279 | +1.9% | 79,873 | -28.3% | 0.00% | – |
| Q1 2021 | $692,000 | -4.8% | 111,372 | +14.2% | 0.00% | – |
| Q4 2020 | $727,000 | +40.9% | 97,508 | +14.5% | 0.00% | – |
| Q3 2020 | $516,000 | -31.6% | 85,170 | -5.6% | 0.00% | – |
| Q2 2020 | $754,000 | +244.3% | 90,264 | +100.3% | 0.00% | – |
| Q1 2019 | $219,000 | -17.7% | 45,067 | +8.3% | 0.00% | – |
| Q4 2018 | $266,000 | -25.5% | 41,609 | -4.3% | 0.00% | – |
| Q3 2018 | $357,000 | -15.8% | 43,488 | +7.1% | 0.00% | – |
| Q2 2018 | $424,000 | – | 40,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |